Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Dermatol Clin ; 18(4): 633-9, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11059371

ABSTRACT

There are many eye cosmetics available to enhance the beauty or improve the appearance of the face. To prevent infection, most eye cosmetics contain preservatives. Fragrance is usually absent to keep the products as safe as possible. Hypoallergenic products contain fewer ingredients and may be more appropriate for patients with sensitive skin.


Subject(s)
Cosmetics/administration & dosage , Eye , Cosmetics/chemistry , Eyebrows , Eyelashes , Female , Humans , Ointments , Powders
2.
Dermatol Nurs ; 11(3): 205-8, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10670337

ABSTRACT

Current therapy of acne vulgaris is very effective. It consists of a combination of topical comedolytic agents, antibacterial agents, and combinations of both. The use of systemic therapy with antibiotics, isotretinoin, and hormones is necessary for cystic acne. The management of patients with the various combinations of topical and systemic medications is discussed.


Subject(s)
Acne Vulgaris/drug therapy , Anti-Bacterial Agents/therapeutic use , Keratolytic Agents/therapeutic use , Acne Vulgaris/immunology , Acne Vulgaris/microbiology , Anti-Bacterial Agents/pharmacology , Humans , Inflammation , Keratolytic Agents/pharmacology , Risk Factors
5.
Cutis ; 52(6): 330, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8293672
7.
Dermatol Clin ; 9(4): 789-93, 1991 Oct.
Article in English | MEDLINE | ID: mdl-1934652

ABSTRACT

It is hoped that this review has given some information to direct the clinician in his approach to his patients. Certainly, we would desire that the incidence of malignant melanoma as well as other skin cancers would start to decrease.


Subject(s)
Melanoma/prevention & control , Skin Neoplasms/prevention & control , Sunscreening Agents/therapeutic use , 4-Aminobenzoic Acid/therapeutic use , Humans
8.
Cutis ; 47(3): 204, 1991 Mar.
Article in English | MEDLINE | ID: mdl-2022132

ABSTRACT

We report an unusual case of pyogenic granuloma that appeared after the application of liquid nitrogen and 27 percent salicylic acid (Duoplant, Stiefel Inc.) to a verruca vulgaris. Only two cases of pyogenic granuloma following cryotherapy appear in the literature and pyogenic granuloma as a complication of salicylic acid application has not been documented.


Subject(s)
Cryosurgery/adverse effects , Granuloma/etiology , Salicylates/adverse effects , Warts/therapy , Granuloma/chemically induced , Hand Dermatoses/chemically induced , Hand Dermatoses/etiology , Humans , Male , Middle Aged , Nitrogen/adverse effects , Salicylic Acid , Warts/drug therapy , Warts/surgery
9.
Dermatol Clin ; 9(1): 29-34, 1991 Jan.
Article in English | MEDLINE | ID: mdl-2022095

ABSTRACT

Cosmetics and toiletries are a very important part of the life of the elderly patient. As physicians, we must know how to recommend them; as people approaching old age ourselves, we should know how to use them. Aging skin is fragile, pale, dry, and sensitive. Sunscreens, emollients, and fragrance-free cosmetics should become part of our recommendations and use. Color and camouflage cosmetics and hair color can make a person look good, and softness is the key to natural beauty.


Subject(s)
Cosmetics , Skin Aging/physiology , Aged , Alopecia/therapy , Cosmetics/administration & dosage , Cosmetics/therapeutic use , Eccrine Glands/physiology , Female , Hair Color , Humans , Male , Nails/pathology
10.
Dermatol Clin ; 9(1): 99-104, 1991 Jan.
Article in English | MEDLINE | ID: mdl-2022102

ABSTRACT

There are sunscreens for every type of skin, activity, and personality. The physician should select a product for his patients intelligently, considering factors such as convenience, protection, sensitization, and comedogenicity.


Subject(s)
Cosmetics , Sunscreening Agents , 4-Aminobenzoic Acid/adverse effects , Cinnamates/therapeutic use , Dermatitis, Contact/prevention & control , Humans , Sunscreening Agents/administration & dosage , Sunscreening Agents/adverse effects , Sunscreening Agents/therapeutic use , United States
11.
Dermatol Clin ; 5(3): 619-26, 1987 Jul.
Article in English | MEDLINE | ID: mdl-3608250

ABSTRACT

Porosity, elasticity, and texture influence the hair's ability to be changed. The types of color--temporary, gradual, natural, semipermanent, and permanent--depend upon the size of the "coloring" molecule to determine whether they penetrate the cortex (permanent) or precipitate on the cuticle. Different types of hair--thick or coarse, fine or thin--have varying affinity for different products and coloring/waving methods. Damaged hair is treated differently from hair with healthy, less porous shafts. Because so many people have color-treated hair today, dermatologists should be aware of all the latest changes and improvements, in order to assist patients with damaged or congenitally deformed hair. Acid-based permanents are becoming the most commonly used. Daily care with shampooing and conditioning has attained its most sophisticated level with the use of anionic and cationic surfactants in all hair-care products. It is also important for the dermatologist to be aware of what help is available for his or her patients. Cosmetic companies are eager to help any patient with severe problems with texture, dullness, over-fine or congenitally defective hair. The physician should send the patient with a severe problem directly to the nearest company headquarters or major city office to have a hair analysis, and receive suggestions from the experts of that company. For patients with moderate to mild problems, the dermatologist should be able to recommend three or four good salons in the local area with which he or she is familiar. Our main goal as physicians is to take care of the entire patient and to enable him or her to have a good self-image.


Subject(s)
Hair Preparations , Hair/anatomy & histology , Hair Dyes , Humans
15.
Am Fam Physician ; 19(4): 99-102, 1979 Apr.
Article in English | MEDLINE | ID: mdl-433728

ABSTRACT

If maximum medical management-hospitalization, tar and sunlight therapy, topical steroids with plastic-wrap occlusion--is not effective, and PUVA is not available, methotrexate therapy should be considered, especially in a patient with severe psoriatic arthritis. It should be used if systemic steroids are inadvisable and if the patient has a normal liver biopsy and no history of alcohol excess. The least toxic and most effective method of administration is three divided doses every 12 hours, once a week.


Subject(s)
Methotrexate/therapeutic use , Psoriasis/drug therapy , Adult , Arthritis/complications , Female , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...